Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.79 CAD | -1.18% | -3.72% | +20.00% |
15/04 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
12/04 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.02% | 297B | |
+7.13% | 147B | |
+56.15% | 128B | |
+18.67% | 81.38B | |
+7.44% | 76B | |
+19.02% | 62.92B | |
+7.94% | 58.63B | |
+8.75% | 48.36B | |
+26.39% | 35.87B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Ovintiv : Morgan Stanley Adjusts Price Target on Ovintiv to $42 From $35, Maintains Overweight Rating